Quantum Biopharma (QNTM) Enterprise Value (2018 - 2026)

Quantum Biopharma has disclosed Enterprise Value across 9 years of filings, most recently posting -$4.1 million for Q1 2026.

• Enterprise Value for Q1 2026 came in at -$4.1 million, up 42.61% year-over-year; the trailing twelve-month figure through Mar 2026 was -$4.1 million (up 42.61% YoY), and the FY2025 annual result was -$4.2 million, up 49.19% from the prior year.
• Enterprise Value came in at -$4.1 million for Q1 2026 at Quantum Biopharma, up from -$4.2 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$2.9 million in Q1 2024 to a low of -$35.8 million in Q1 2022.
• The 5-year median for Enterprise Value is -$7.2 million (2024), against an average of -$12.8 million.
• Across the five-year window, Enterprise Value surged 82.27% in 2023 and tumbled 147.02% in 2025, its largest moves.
• Quantum Biopharma's Enterprise Value stood at -$17.0 million in 2022, then declined by 4.88% to -$17.8 million in 2023, then soared by 53.74% to -$8.2 million in 2024, then soared by 49.19% to -$4.2 million in 2025, then grew by 1.02% to -$4.1 million in 2026.
• The last three Enterprise Value figures came in at -$4.1 million (Q1 2026), -$4.2 million (Q4 2025), and -$6.1 million (Q3 2025), per Business Quant data.